Subject:

PARP1   New Search


View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects

Apoptosis  6 times
Protein  5 times
Adenosine diphosphate ribose  5 times
Polymerase  4 times
Enzyme inhibitor  4 times
DNA  4 times
Reactive oxygen species  3 times
Chemotherapy  3 times
Nicotinamide adenine dinucleotide  2 times
Mouse  2 times
Middle cerebral artery  2 times
Gene  2 times
DNA repair  2 times
Cell cycle  2 times
Caspase 3  2 times
Caspase  2 times
Antioxidant  2 times
Triple-negative breast cancer  1 time
Tight junction  1 time
TUNEL assay  1 time
TNBC  1 time
Substantia nigra  1 time
Stroke  1 time
Sarcoma  1 time
Reperfusion injury  1 time
Radiation therapy  1 time
RNA interference  1 time
Pyrophosphate  1 time
Protein kinase B  1 time
Progression-free survival  1 time
Pleiotropy  1 time
Phosphoinositide 3-kinase  1 time
Phenotype  1 time
Pharmacophore  1 time
Oxidative stress  1 time
Ovarian cancer  1 time
Ornithine  1 time
Oncology  1 time
Nitrogen  1 time
Necrosis  1 time
NMDA receptor  1 time
NADPH oxidase  1 time
Microscopy  1 time
Microglia  1 time
Metabolism  1 time
Melanoma  1 time
MCF-7  1 time
Lysine  1 time
List of breast cancer cell lines  1 time
Liposarcoma  1 time
Ion  1 time
Intraperitoneal injection  1 time
Inflammation  1 time
IC50  1 time
Hypothermia  1 time
Homologous recombination  1 time
HaCaT  1 time
H2AFX  1 time
Glutamic acid  1 time
Genome  1 time
Fluorouracil  1 time
Ester  1 time
Epithelium  1 time
Epigenetics  1 time
Docking (molecular)  1 time
Diabetes mellitus type 2  1 time
DNA methylation  1 time
Catalysis  1 time
Carboxylic acid  1 time
Breast cancer  1 time
Brain ischemia  1 time
Blood plasma  1 time
Bioavailability  1 time
Bcl-2-associated X protein  1 time
Bcl-2  1 time
BRCA2  1 time
BRCA1  1 time
Astrocyte  1 time
Asphyxia  1 time
Annexin  1 time
Alanine  1 time
Adenosine triphosphate  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)




Questions?

Drop us a message.